AKUMS DRUGS & PHARMACEUTICALS
|
|
BOM : 544222     NSE : AKUMS     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
Mar 13,2025 |
Price(EOD): ₹ 510.55
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 8,036.06 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
AKUMS DRUGS & PHARMACEUTICALS | 1.3% | -5.7% | NA |
SUN PHARMACEUTICAL INDUSTRIES | 4.6% | -0.9% | 5.3% |
DIVIS LABORATORIES | 0.5% | -5.5% | 57.2% |
CIPLA | 0.2% | 0.6% | -3.3% |
TORRENT PHARMACEUTICALS | -0.4% | -1.5% | 14.8% |
DR REDDYS LABORATORIES | -2.2% | -8.6% | -13.4% |
MANKIND PHARMA | -4.9% | -10.2% | 0.3% |
ZYDUS LIFESCIENCES | -2.1% | -6.3% | -10.6% |
LUPIN | -3% | -4.7% | 17.3% |
FUNDAMENTAL ANALYSIS OF AKUMS DRUGS & PHARMACEUTICALS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF AKUMS DRUGS & PHARMACEUTICALS
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
20.65
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 389.17 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] 11.33
P/B Calculated based on Book Value of Rs 709.50 Cr
[Latest Year - Mar2024 - Consolidated Results ] 1.94
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 4,145.45 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
NA 27349% - |
SHARE PRICE MOMENTUM OF AKUMS DRUGS & PHARMACEUTICALS
AKUMS DRUGS & PHARMACEUTICALS vs SENSEX
DEBT OF AKUMS DRUGS & PHARMACEUTICALS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
1.57 0.47 0.66 0.9 |
0.69 0.75 0.58 0.67 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF AKUMS DRUGS & PHARMACEUTICALS
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2024 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF AKUMS DRUGS & PHARMACEUTICALS
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-2.19% 0.15% -0.58% -0.51% |
-14.46% -20.07% 4.51% 102.86% |
QtrlyTrend |
-2 | |
Latest Qtr: Dec2024 | ||
Quarterly Result Analysis → |
AKUMS DRUGS & PHARMACEUTICALS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE IPO | -3.3% | -10% | -3.2% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY 500 | -1.3% | -5.6% | -1.3% |
NIFTY TOTAL MARKET | -1.4% | -5.8% | -1.2% |
NIFTY500 MULTICAP 50:25:25 | -1.7% | -6.6% | -1.5% |
NIFTY MIDSMALLCAP 400 | -2.5% | -8.6% | -2.1% |
NIFTY SMALLCAP 250 | -2.8% | -10.2% | -4.8% |
You may also like the below Video Courses
FAQ about AKUMS DRUGS & PHARMACEUTICALS
Is AKUMS DRUGS & PHARMACEUTICALS good for long term investment?
As on Mar 13,2025, the Fundamentals of AKUMS DRUGS & PHARMACEUTICALS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of AKUMS DRUGS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is AKUMS DRUGS & PHARMACEUTICALS UnderValued or OverValued?
As on Mar 13,2025, AKUMS DRUGS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of AKUMS DRUGS & PHARMACEUTICALS ?
As on Mar 13,2025, the Intrinsic Value of AKUMS DRUGS & PHARMACEUTICALS is Rs. 1.86 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. -7.58
Fair Value [Median EV / Sales Model] : Rs. 1.86
Fair Value [Median Price / Sales Model] : Rs. 0.00
Estimated Median Fair Value of AKUMS DRUGS & PHARMACEUTICALS : Rs. 1.86
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.